149 related articles for article (PubMed ID: 38554942)
1. Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials.
Shrateh ON; Kumar KA; Jawed A; Shuja MH; Shamsi HUR; Naasan M
J Gynecol Obstet Hum Reprod; 2024 Jun; 53(6):102783. PubMed ID: 38554942
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of cabergoline vs pyridoxine for lactation inhibition-a randomized controlled trial.
Dayan-Schwartz A; Yefet E; Massalha M; Hosari-Mhameed S; Remer-Gross C; Pasand E; Nachum Z
Am J Obstet Gynecol; 2024 May; 230(5):561.e1-561.e8. PubMed ID: 37827268
[TBL] [Abstract][Full Text] [Related]
3. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Rains CP; Bryson HM; Fitton A
Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
[TBL] [Abstract][Full Text] [Related]
4. Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.
Tulloch KJ; Dodin P; Tremblay-Racine F; Elwood C; Money D; Boucoiran I
J Int AIDS Soc; 2019 Jun; 22(6):e25322. PubMed ID: 31183987
[TBL] [Abstract][Full Text] [Related]
5. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
[TBL] [Abstract][Full Text] [Related]
6. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
Webster J
Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Tang H; Mourad S; Zhai SD; Hart RJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
[TBL] [Abstract][Full Text] [Related]
8. Is pyridoxine effective and safe for post-partum lactation inhibition? A systematic review.
AlSaad D; Awaisu A; Elsalem S; Abdulrouf PV; Thomas B; AlHail M
J Clin Pharm Ther; 2017 Aug; 42(4):373-382. PubMed ID: 28425124
[TBL] [Abstract][Full Text] [Related]
9. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KD
Cochrane Database Syst Rev; 2001; 2001(1):CD001519. PubMed ID: 11279721
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of puerperal lactation: A comparative study of bromocriptine and pyridoxine.
Boes EG
S Afr Med J; 1980 May; 57(22):900-3. PubMed ID: 6996132
[TBL] [Abstract][Full Text] [Related]
11. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic activity of sarpogrelate and dopamine D
Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R
BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339
[TBL] [Abstract][Full Text] [Related]
13. Cabergoline: a new drug for the treatment of hyperprolactinaemia.
Ferrari C; Piscitelli G; Crosignani PG
Hum Reprod; 1995 Jul; 10(7):1647-52. PubMed ID: 8582955
[TBL] [Abstract][Full Text] [Related]
14. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
[TBL] [Abstract][Full Text] [Related]
15. Safety of Cabergoline for Postpartum Lactation Inhibition or Suppression: A Systematic Review.
Harris K; Murphy KE; Horn D; MacGilivray J; Yudin MH
J Obstet Gynaecol Can; 2020 Mar; 42(3):308-315.e20. PubMed ID: 31285168
[TBL] [Abstract][Full Text] [Related]
16. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis.
dos Santos Nunes V; El Dib R; Boguszewski CL; Nogueira CR
Pituitary; 2011 Sep; 14(3):259-65. PubMed ID: 21221817
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
Vecchione A; Baccolo M
Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
[No Abstract] [Full Text] [Related]
19. Inhibiting the onset of lactation. Is cabergoline an alternative to bromocriptine?
Prescrire Int; 2015 Nov; 24(165):276-7. PubMed ID: 26688910
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
